Preeclampsia Ages the Placenta Faster and Antioxidants Can Slow It

Late-onset preeclampsia (LOPE), which develops after 34 weeks of gestation and accounts for the majority of preeclampsia cases, is one of the most serious pregnancy complications worldwide. It is defined by hypertension and organ dysfunction and resolves only with delivery of the placenta. While oxidative stress and inflammation are known features of LOPE, the molecular mechanisms driving accelerated placental deterioration have remained poorly understood. This study provides the most comprehensive characterization to date of placental aging in LOPE, revealing a coherent biological story centered on oxidative stress, telomere biology, and cellular senescence.

The researchers analyzed term placentas from 37–42 weeks' gestation from both healthy controls and LOPE pregnancies. LOPE placentas showed consistently shorter telomeres across all gestational ages (mean 3.68 kB versus 4.12 kB in controls), with a gestational age-dependent decline evident from 39 weeks onward in all groups. Cellular senescence as measured by SA-β-galactosidase staining was significantly elevated in LOPE placentas (mean 43.2% positive trophoblasts versus 31.8% in controls). DNA damage markers (γH2AX foci) were also elevated in LOPE (median 37.1% positive nuclei versus 29.1% in controls), and the syncytiotrophoblast-to-cytotrophoblast ratio was higher (median 9.27 versus 8.03), consistent with accelerated trophoblast maturation and terminal differentiation.

To test mechanistic drivers, the team used trophoblast organoids derived from 37-week placentas and cultured them for four weeks — a system they validated as faithfully recapitulating in vivo aging trajectories. Treatment with superoxide dismutase (SOD) over four weeks significantly preserved telomere length in LOPE organoids (mean 3.62 kB with SOD versus 3.21 kB without), reduced 8-OHdG oxidative stress markers by 17.6%, and reduced γH2AX DNA damage intensity by 13.2%. Critically, SOD also partially normalized the sFlt-1/PlGF angiogenic ratio — the primary clinical biomarker of preeclampsia — by reducing excess sFlt-1 secretion, directly linking oxidative stress to the placental secretory dysfunction that harms maternal vasculature.

In contrast, inhibition of the NLRP3 inflammasome using MCC950 — despite confirming effective suppression of NLRP3 protein — had no effect on telomere length, senescence burden, DNA damage, or angiogenic factor secretion in LOPE organoids. Paradoxically, MCC950 increased senescence in control organoids. While maternal blood collected at 34 weeks confirmed that systemic inflammation (elevated IL-18, gasdermin D, and LDH) is present in LOPE pregnancies in vivo, these findings strongly suggest that placental aging is driven primarily by oxidative stress rather than inflammasome-mediated inflammation.

A particularly novel finding was the identification of reduced telomeric repeat-containing RNAs (TERRAs) as a molecular hallmark of LOPE. TERRAs form protective R-loops at chromosome ends and help stabilize telomeres. Multiple TERRA species (20q, 10q, 13q, XY) were significantly downregulated in LOPE placental tissue. Antisense oligonucleotide-mediated TERRA depletion in organoids exacerbated telomere erosion and senescence, confirming a functional causal role. Additionally, SOD treatment promoted syncytial knot formation in LOPE organoids — a somewhat paradoxical finding, as syncytial knots are a histological marker of accelerated placental aging, suggesting that antioxidant intervention may accelerate certain downstream maturation processes even while protecting telomeres. The study is a preprint and awaits peer review, and sample sizes for some organoid experiments are not fully detailed in the available text.